Shopping Cart 0
Cart Subtotal
AED 0

Stroke Diagnostics and Therapeutics Market by Diagnostics (Magnetic Resonance Imaging, Computed Tomography Scan, Electrocardiography Carotid Ultrasound, Cerebral Angiography and Others) by Therapeutics (Tissue Plasminogen Activator, Antiplatelet, Antihypertensive, and Anticoagulant) for Haemorrhagic Stroke and Ischemic Stroke - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15410

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 23117

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 30824
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

The report covers forecast and analysis for the stroke diagnostics and therapeutics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the stroke diagnostics and therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the stroke diagnostics and therapeutics market on a global level. This report offers comprehensive coverage on global stroke diagnostics and therapeutics market along with, market trends, drivers, and restraints of stroke diagnostics and therapeutics market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the stroke diagnostics and therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts. The study provides a decisive view on the stroke diagnostics and therapeutics market by segmenting the market based on diagnostics, therapeutics, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The diagnostics market covered under this study includes magnetic resonance imaging, computed tomography scan, electrocardiography, and carotid ultrasound. The therapeutics segmentation includes tissue plasminogen activator, antiplatelet, antihypertensive and anticoagulant. The application segmentation includes haemorrhagic stroke and ischemic stroke. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into the U.S., U.K., Germany, France, Japan, China, India, and Brazil. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global stroke diagnostics and therapeutics market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck Co., Inc This report segments the global stroke diagnostics and therapeutics market as follows: Global Stroke Diagnostics and Therapeutics Market: Diagnostics Analysis Magnetic Resonance Imaging (MRI) Computed Tomography Scan (CT scan) Electrocardiography Carotid Ultrasound Cerebral Angiography Others Global Stroke Diagnostics and Therapeutics Market: Therapeutics Analysis Tissue Plasminogen Activator Antiplatelet Antihypertensive Anticoagulant Global Stroke Diagnostics and Therapeutics Market: Application Analysis Haemorrhagic Stroke Ischemic Stroke Global Stroke Diagnostics and Therapeutics Market: Regional Segment Analysis North America U.S. Europe U.K. Germany France Asia Pacific China Japan India Latin America Brazil Middle East And Africa

READ MORE

Table Of Content

Scope

Chapter 1. Introduction 1.1. Report Description And Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter 2. Executive Summary 2.1. Global Stroke Diagnostics and Therapeutics Market, 2015-2021 (USD Billion) 2.2. Global Stroke Diagnostics and Therapeutics Market: Snapshot Chapter 3. Stroke Diagnostics and Therapeutics Market Dynamics 3.1. Introduction 3.2. Value Chain Analysis 3.3. Market Drivers 3.3.1. Global Stroke Diagnostics and Therapeutics Market Drivers: Impact Analysis 3.3.2. Large Patient Pool Along With Rising Aging Population 3.3.3. Rising Incidences Of Diabetes And Large Number Of Tobacco Users 3.4. Market Restraints 3.4.1. Global Stroke Diagnostics and Therapeutics Market Restraints: Impact Analysis 3.4.2. High Cost Of Treatment 3.4.3. Lack Of Transparent Reimbursement 3.5. Opportunities 3.5.1. Covering Untapped Market 3.6. Porters Five Forces Analysis 3.6.1. Bargaining Power Of Suppliers 3.6.2. Bargaining Power Of Buyers 3.6.3. Threat From New Entrants 3.6.4. Threat From New Substitutes 3.6.5. Degree Of Competition 3.7. Market Attractiveness Analysis 3.7.1. Market Attractiveness Analysis, By Diagnostics Segment 3.7.2. Market Attractiveness Analysis, By Therapeutics Segment 3.7.3. Market Attractiveness Analysis, By Application Segment 3.7.4. Market Attractiveness Analysis, By Regional Segment Chapter 4. Global Stroke Diagnostics and Therapeutics Market Competitive Landscape 4.1. Company Market Share, 2015 (Subject To Data Availability) 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Type Launch 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures 4.2.4. Research And Development, Regional Expansion 4.3. Type Portfolio Chapter 5. Global Stroke Diagnostics and Therapeutics Market Diagnostics Analysis 5.1. Global Stroke Diagnostics and Therapeutics Market: Diagnostics Segment Overview 5.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Diagnostics, 2015 And 2021 5.2. Magnetic Resonance Imaging 5.2.1. Global Magnetic Resonance Imaging Market, 2015 2021 (USD Billion) 5.3. Computed Tomography Scan 5.3.1. Global Computed Tomography Scan Market, 2015 2021 (USD Billion) 5.4. Electrocardiography 5.4.1. Global Electrocardiography Market, 2015 2021 (USD Billion) 5.5. Carotid Ultrasound 5.5.1. Global Carotid Ultrasound Market, 2015 2021 (USD Billion) 5.6. Cerebral Angiography 5.6.1. Global Cerebral Angiography Market, 2015 2021 (USD Billion) 5.7. Others 5.7.1.Global Others Market, 2015 2021 (USD Billion) Chapter 6. Global Stroke Diagnostics and Therapeutics Market Therapeutics Segment Analysis 6.1. Global Stroke Diagnostics and Therapeutics Market: Therapeutics Segment Overview 6.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Therapeutics, 2015 And 2021 6.2. Tissue Plasminogen Activator 6.2.1. Global Stroke Diagnostics and Therapeutics Market For Tissue Plasminogen Activator, 2015 2021 (USD Billion) 6.3. Antiplatelet 6.3.1. Global Stroke Diagnostics and Therapeutics Market for Antiplatelet, 2015 2021 (USD Billion) 6.4. Antihypertensive 6.4.1. Global Stroke Diagnostics and Therapeutics Market for Antihypertensive, 2015 2021 (USD Billion) 6.5. Anticoagulant 6.5.1. Global Stroke Diagnostics and Therapeutics Market for Anticoagulant, 2015 2021 (USD Billion) Chapter 7. Global Stroke Diagnostics and Therapeutics Market Application Segment Analysis 7.1. Global Stroke Diagnostics and Therapeutics Market: Application Segment Overview 7.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Application, 2015 And 2021 7.2. Haemorrhagic Stroke 7.2.1. Global Stroke Diagnostics and Therapeutics Market For Haemorrhagic Stroke , 2015 2021 (USD Billion) 7.3. Ischemic Stroke 7.3.1. Global Stroke Diagnostics and Therapeutics Market for Ischemic Stroke, 2015 2021 (USD Billion) Chapter 8. Global Stroke Diagnostics and Therapeutics Market Regional Segment Analysis 8.1. Global Stroke Diagnostics and Therapeutics Market: Regional Overview 8.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Region, 2015 And 2021 8.2. North America 8.2.1. North America Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 , (USD Billion) 8.2.2. North America Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 , (USD Billion) 8.2.3. North America Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 , (USD Billion) 8.2.4. U.S. 8.2.4.1. U.S. Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.2.5. U.S. 8.2.5.1. U.S. Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.2.6. U.S. 8.2.6.1. U.S. Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.3. Europe 8.3.1. Europe Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.3.2. Europe Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.3.3. Europe Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.3.4. Germany 8.3.4.1. Germany Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021, (USD Billion) 8.3.4.2. Germany Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021, (USD Billion) 8.3.4.3. Germany Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021, (USD Billion) 8.3.5. France 8.3.5.1. France Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021, (USD Billion) 8.3.5.2. France Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021, (USD Billion) 8.3.5.3. France Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021, (USD Billion) 8.3.6. U.K. 8.3.6.1. U.K. Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.3.6.2. U.K. Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.3.6.3. U.K. Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.4. Asia Pacific 8.4.1. Asia Pacific Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.4.2. Asia Pacific Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.4.3. Asia Pacific Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.4.4. China 8.4.4.1. China Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.4.4.2. China Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.4.4.3. China Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.4.5. Japan 8.4.5.1. Japan Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.4.5.2. Japan Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.4.5.3. Japan Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.4.6. India 8.4.6.1. India Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.4.6.2. India Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.4.6.3. India Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.5. Latin America 8.5.1. Latin America Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.5.2. Latin America Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.5.3. Latin America Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.5.4. Brazil 8.5.4.1. Brazil Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.5.4.2. Brazil Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.5.4.3. Brazil Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) 8.6. Middle East And Africa 8.6.1. Middle East And Africa Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015 2021 (USD Billion) 8.6.2. Middle East And Africa Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015 2021 (USD Billion) 8.6.3. Middle East And Africa Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015 2021 (USD Billion) Chapter 9. Company Profile 9.1. Abbott Laboratories, 9.1.1. Overview 9.1.2. Financials 9.1.3. Product Portfolio 9.1.4. Business Strategy 9.1.5. Recent Developments 9.2. Medtronic plc, 9.2.1. Overview 9.2.2. Financials 9.2.3. Product Portfolio 9.2.4. Business Strategy 9.2.5. Recent Developments 9.3. Boston Scientific Corporation, 9.3.1. Overview 9.3.2. Financials 9.3.3. Product Portfolio 9.3.4. Business Strategy 9.3.5. Recent Developments 9.4. Cordis Corporation, 9.4.1. Overview 9.4.2. Financials 9.4.3. Product Portfolio 9.4.4. Business Strategy 9.4.5. Recent Developments 9.5. Koninklijke Philips N.V., 9.5.1. Overview 9.5.2. Financials 9.5.3. Product Portfolio 9.5.4. Business Strategy 9.5.5. Recent Developments 9.6. GE Healthcare,. 9.6.1. Overview 9.6.2. Financials 9.6.3. Product Portfolio 9.6.4. Business Strategy 9.6.5. Recent Developments 9.7. Siemens AG 9.7.1. Overview 9.7.2. Financials 9.7.3. Product Portfolio 9.7.4. Business Strategy 9.7.5. Recent Developments 9.8. Stryker Corporation 9.8.1. Overview 9.8.2. Financials 9.8.3. Product Portfolio 9.8.4. Business Strategy 9.8.5. Recent Developments 9.9. Merck Co., Inc. 9.9.1. Overview 9.9.2. Financials 9.9.3. Product Portfolio 9.9.4. Business Strategy 9.9.5. Recent Developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com